| THURSDAY, FEBRUARY 04, 2010 |
| 4:30 PM | Exelixis Announces February 9 Webcast of Presentation at the 12th Annual BioCEO and Investor Conference - BusinessWire |
 |
| WEDNESDAY, DECEMBER 09, 2009 |
| 6:30 AM | Exelixis Announces January 12 Webcast of Presentation at the 28th Annual J.P. Morgan Healthcare Conference - BusinessWire |
|
| WEDNESDAY, NOVEMBER 25, 2009 |
| 2:15 PM | Exelixis Announces December 1 Webcast of Presentation at Piper Jaffray's 21st Annual Healthcare Conference - BusinessWire |
|
| TUESDAY, NOVEMBER 24, 2009 |
| 8:30 AM | Exelixis Announces Webcast of Its Fifth Annual R&D Day on December 2 - BusinessWire |
|
| WEDNESDAY, NOVEMBER 18, 2009 |
| 12:30 PM | Exelixis Reports Encouraging Phase 1 Data for the PI3K Inhibitor Xl147 (SAR245408) in Combination with Erlotinib at the AACR-NCI-EORTC Conference - BusinessWire |
|
| TUESDAY, NOVEMBER 17, 2009 |
| 12:30 PM | Exelixis Reports Encouraging Phase 1 Data for the PI3K Inhibitor XL147 (SAR245408) in Combination with Paclitaxel and Carboplatin at the AACR-NCI-EORTC Conference - BusinessWire |
|
| FRIDAY, NOVEMBER 13, 2009 |
| 8:30 AM | Exelixis Announces November 18 Webcast of Presentation at Lazard's 6th Annual Healthcare Conference - BusinessWire |
|
